Competitive Intelligence, Diseases 0 Comments

Summarized clinical trials landscape for non-small cell lung cancer as of 26th dec 2016. Data source: Clinical trials intelligence By: TrialsFind PRO NSCLC clinical trials overview Of the 15257 open cancer studies on, 988 (6.5%) are studies for NSCLC. Merck, Novartis and Astrazeneca are the most active industry players in NSCLC. 19% of

Read More